我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
158
2 进行中
药物批准
1
批准总数
监管机构
监管机构数
成立时间
N/A
已完成
132
83.5%
尚未招募
2
1.3%
招募中
4
2.5%
终止
14
8.9%
Unknown
0.6%
撤回
5
3.2%
NMPA
National Medical Products Administration
- At least 13 infants across 10 states have been hospitalized with botulism after consuming ByHeart Whole Nutrition Infant Formula between August and November 2024. - Preliminary tests by California health officials detected bacteria that produces botulism toxin in the recalled formula, marking an extremely rare occurrence in powdered infant formula. - ByHeart voluntarily recalled two specific lots of their formula with lot numbers 206VABP/251131P2 and 206VABP/251261P2, both with December 1, 2026 expiration dates. - All affected infants received BabyBIG treatment, the only available therapy for infant botulism, and no deaths have been reported in this outbreak.
